Universe Pharmaceuticals INC (UPC)
USD 3.52
(-0.28%)
USD 3.52
(-0.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 13.84 Million USD | -50.6% |
| 2022 | 28.91 Million USD | 146.34% |
| 2021 | 11.73 Million USD | 213.46% |
| 2020 | 3.74 Million USD | 11.54% |
| 2019 | 3.35 Million USD | -8.01% |
| 2018 | 3.64 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.98 Million USD | 0.0% |
| 2023 Q4 | 7.73 Million USD | 0.0% |
| 2023 FY | 14.28 Million USD | -50.6% |
| 2023 Q2 | 5.86 Million USD | 0.0% |
| 2022 Q4 | 18.19 Million USD | 0.0% |
| 2022 FY | 28.91 Million USD | 146.34% |
| 2022 Q2 | 10.93 Million USD | 0.0% |
| 2021 FY | 11.73 Million USD | 213.46% |
| 2021 Q2 | 2.28 Million USD | 0.0% |
| 2021 Q4 | 9.25 Million USD | 0.0% |
| 2020 Q4 | 935.99 Thousand USD | 0.0% |
| 2020 FY | 3.74 Million USD | 11.54% |
| 2020 Q3 | 935.99 Thousand USD | 0.0% |
| 2020 Q2 | 935.99 Thousand USD | 0.0% |
| 2020 Q1 | 935.99 Thousand USD | 2.44% |
| 2019 Q2 | 913.66 Thousand USD | 0.0% |
| 2019 FY | 3.35 Million USD | -8.01% |
| 2019 Q4 | 913.66 Thousand USD | 0.0% |
| 2019 Q3 | 913.66 Thousand USD | 0.0% |
| 2018 Q3 | 938.14 Thousand USD | 0.0% |
| 2018 Q4 | 938.14 Thousand USD | 0.0% |
| 2018 Q2 | 938.14 Thousand USD | 0.0% |
| 2018 FY | 3.64 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -67.722% |
| Alpha Teknova, Inc. | 45.85 Million USD | 69.816% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 92.937% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 69.14% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 91.306% |
| Cosmos Health Inc. | 26.18 Million USD | 47.13% |
| Journey Medical Corporation | 54.59 Million USD | 74.646% |
| Embecta Corp. | 528.4 Million USD | 97.38% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 94.909% |
| Dynavax Technologies Corporation | 219.14 Million USD | 93.684% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 97.654% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 95.759% |
| PainReform Ltd. | 9.58 Million USD | -44.427% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -5.466% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -5.466% |
| SCYNEXIS, Inc. | 51.84 Million USD | 73.303% |
| Safety Shot Inc | 12.1 Million USD | -14.304% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -350.996% |
| Procaps Group, S.A. | 199.47 Million USD | 93.061% |
| Theratechnologies Inc. | 72.75 Million USD | 80.975% |
| Harrow Health, Inc. | 89.97 Million USD | 84.615% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -46.537% |
| Biofrontera Inc. | 39.95 Million USD | 65.36% |
| DURECT Corporation | 43.71 Million USD | 68.336% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 97.383% |
| Cronos Group Inc. | 96.7 Million USD | 85.687% |
| OptiNose, Inc. | 85.1 Million USD | 83.735% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 94.037% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 64.647% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 244.775% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 95.594% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -42.248% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 67.84% |
| Radius Health, Inc. | 265.92 Million USD | 94.795% |
| ProPhase Labs, Inc. | 37.85 Million USD | 63.432% |
| Phibro Animal Health Corporation | 260.29 Million USD | 94.682% |
| Procaps Group S.A. | 187.24 Million USD | 92.608% |
| Alvotech | 285.43 Million USD | 95.151% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -40.885% |
| Viatris Inc. | 5.96 Billion USD | 99.768% |
| Rockwell Medical, Inc. | 15.37 Million USD | 9.965% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 76.868% |
| SIGA Technologies, Inc. | 22.04 Million USD | 37.205% |
| Tilray Brands, Inc. | 251.35 Million USD | 94.493% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 71.773% |
| Shineco, Inc. | 17.94 Million USD | 22.878% |
| PetIQ, Inc. | 192.72 Million USD | 92.818% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -246.816% |
| Incannex Healthcare Limited | 30.05 Million USD | 53.942% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.133% |
| Alimera Sciences, Inc. | 62.64 Million USD | 77.903% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -1715.351% |
| Assertio Holdings, Inc. | 368.58 Million USD | 96.245% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -135.184% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 22.274% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 34.612% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 34.218% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 91.609% |
| Hempacco Co., Inc. | 7.59 Million USD | -82.216% |
| Talphera, Inc. | 11.99 Million USD | -15.407% |
| Alvotech | 285.43 Million USD | 95.151% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 90.163% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 95.987% |
| Currenc Group, Inc. | 24 Million USD | 42.33% |
| Kamada Ltd. | 45.42 Million USD | 69.529% |
| Indivior PLC | 911 Million USD | 98.481% |
| Evoke Pharma, Inc. | 12.4 Million USD | -11.542% |
| Flora Growth Corp. | 10.57 Million USD | -30.843% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 34.218% |
| Evolus, Inc. | 189.75 Million USD | 92.706% |
| HUTCHMED (China) Limited | 436.23 Million USD | 96.827% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 91.02% |
| Akanda Corp. | 3.48 Million USD | -297.355% |